Red biotechnology(Bio-pharmaceutical) is a process that utilizes organisms to improve health care and help the body to fight diseases. It is a branch of modern biotechnology which is utilized in the field of medicine. Red biotechnology is not only limited to the pharmaceutical industry but also to the medical sector as it facilitates the alleviation of human suffering and enhances the quality of life.
It has become tremendous use in clinical research and trials, gene therapy and in diagnostic of the gene. Genetic engineering, production, and development of various medicines to treat different life-threatening diseases, which is a part of the benefits of red biotechnology.
Many branches of medicine in which this technology assumes to have great importance are the production of combination vaccines like Hepatitis B, Hepatitis A, DPT, and polio vaccine that is meant to be injected. This technology is beneficial in the field of poultry farming as well as in tissue engineering.
Other areas where red biotechnology is useful are in the fields of cancer research, veterinary, production of biochips and so on. Red biotechnology brings all the biotechnology uses to medicine.
Table of Contents
Red biotechnology Includes
Producing vaccines and antibiotics
Developing new drugs
Molecular diagnostics techniques
Development of genetic engineering
Some examples of red biotechnology are regenerative medicine, gene therapy, cell therapy and medicines based on biological molecules such as therapeutic antibodies. Red biotechnology applications is a long and expensive process which occurs in order to introduce a new drug into the market.
- Red biotechnology has been making waves in the pharmaceutical industry. When you hear the term red biotechnology applications, you may not know what it is referring to, but in the medical industry, it refers to medical drugs that are produced by applying methods of biotechnology.
- Some of the biopharmaceuticals are produced through the use of biotechnology include nucleic acids, proteins, antibodies, DNA and RNA. These are all used for in-vivo therapeutic or diagnostic purposes. They are different than other pharmaceuticals because they are developed using methods of biotechnology rather than direct extraction
- The first biopharmaceutical that was approved for use is actually insulin. Insulin was created using recombinant technology with DNA. Since the inception of insulin being released and used in the medical community, there have been continuous strides in the field of biopharmaceuticals. Most of these are derived from forms of living organisms.
- Once a biopharmaceutical is created and approved for use, it typically goes through the process of being patented to give it exclusive rights for manufacturing and production. Because of the high cost usually associated with using biotechnology methods in creating biopharmaceuticals, it is important to the creator of the new drug to be able to maintain rights to it to help absorb a portion of the cost it took in the stages of development.
Future of Red-Biotechnology
Every day Science moves little steps forward, contributing to the progress of the society. However, a single invention revolutionizes the world.
3D-printing is now boosting another revolution-3D-printing in biomedicine. 3D-bioprinting represents the future of the Red-Biotech. This technology will be able to build organs using biocompatible materials and human cells. This will replace the allograft transplants, eliminating waiting lists that often make the difference between life and death. This will also replace animal tests and provide more predictive, less expensive experimental models. The high innovation content of this technology can make the difference between being out of date and new.